Follow The Filings

GYRE Gyre Therapeutics

Gyre Therapeutics earnings company data as of 4:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by GYRE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GYRE insider trades
  • None no insider bought on the open market
  • $870K sold by 1 insider outside a trading plan
  • $83K sold by 1 insider under 10b5-1 plans
  1. Weiguo Ye COO
    Sale
    $69K 11,000 shares at $6.25 1.5% of stake
    Traded Jun 9–18 Filed Jun 22
    ↗
  2. Weiguo Ye COO
    Sale
    $17K 2,800 shares at $6.17 0.4% of stake
    Traded Jun 11 Filed Jun 15
    ↗
  3. Weiguo Ye COO
    Sale
    $129K 20,918 shares at $6.16 2.9% of stake
    Traded Jun 9–10 Filed Jun 11
    ↗
  4. Weiguo Ye COO
    Sale
    $219K 34,976 shares at $6.25 4.8% of stake
    Traded Jun 4–5 Filed Jun 8
    ↗
  5. Weiguo Ye COO
    Sale
    $46K 7,500 shares at $6.09 1.1% of stake
    Traded May 22–26 Filed May 27
    ↗
  6. Weiguo Ye COO
    Sale
    $137K 22,220 shares at $6.15 3.1% of stake
    Traded May 20–21 Filed May 22
    ↗
  7. Weiguo Ye COO
    Sale
    $59K 9,320 shares at $6.38 1.3% of stake
    Traded May 18–19 Filed May 20
    ↗
  8. Weiguo Ye COO
    Sale
    $195K 28,680 shares at $6.79 3.9% of stake
    Traded May 14–15 Filed May 18
    ↗
  9. Ying Luo CEO
    Planned sale
    $83K 10,315 shares at $8.04 0.4% of stake
    Traded May 5–6 Filed May 7
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.01,3.02,3.03,5.02,5.03,7.01,9.01 Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated about 24 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.